IGM Biosciences LLC
IGMS · NASDAQ
Price unavailable right now.
No price history for this range.
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 131.5% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY25 | -$0.306 | $1.58 | +616.3% |
| Q1 FY25 | -$0.4182 | -$0.51 | −22.0% |
| Q4 FY24 | -$0.7528 | -$0.61 | +19.0% |
| Q3 FY24 | -$0.816 | -$1.01 | −23.8% |
| Q2 FY24 | -$0.0385 | -$0.79 | −1951.9% |
| Q1 FY24 | -$0.848 | -$0.83 | +2.1% |
| Q4 FY23 | -$1.05 | -$1.01 | +4.1% |
| Q3 FY23 | -$1.24 | -$1.04 | +15.9% |
Earnings calls
- Special Call - IGM Biosciences, Inc.
- J.P. Morgan 42nd Annual Healthcare Conference 2024
- Morgan Stanley 21st Annual Global Healthcare Conference 2023
- Special Call - IGM Biosciences, Inc.
- Bank of America Securities 2023 Healthcare Conference
- Stifel 2023 Targeted Oncology Days
- Earnings call Q4 2022
- 41st Annual J.P. Morgan Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.